Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VC005 in Adolescent Subjects With Non-Segmental Vitiligo
NCT07828639Phase 2Not yet recruiting
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Sep 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 2 trial of VC-005 in Vitiligo, sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
VC-005
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07828639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07828639.